No Data
No Data
Are Investors Undervaluing Addus HomeCare Corporation (NASDAQ:ADUS) By 43%?
Addus HomeCare Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $150
Q4 Rundown: Addus HomeCare (NASDAQ:ADUS) Vs Other Senior Health, Home Health & Hospice Stocks
Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Might Deserve Your Attention Today
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says